illumina strategic initiatives

Terms and Conditions | Catalyze Patient Access to Genomic Testing, Patients Catalyze Patient Access to Genomic Testing, Patients Get answers to common questions about Illumina Accelerator. Publication Summaries, Specialized Oncology 500 Product Family, Peer-Reviewed A full description of Illumina Accelerator, the terms and conditions of participation, and the rights and obligations of Illumina and selected participants will be available upon request. For Research Use Only. The Sr Director, Corporate & Strategic Planning reports to the Vice President, Corporate & Strategic Planning and is primarily responsible for the evolution and management of Illumina's … Dowdy holds a Master of Business Administration from Pepperdine University and an undergraduate degree from the University of California, Berkeley. Table Illumina Strategic initiatives. Genome Analyzer systems. Table Roche Production, Value, Price, Gross Margin 2014-2019. Having spent the majority of her career in Europe, Dowdy currently resides in London. Hear from graduates about their experiences. Illumina, Inc. (Nasdaq: ILMN) announced a global strategic partnership with IDbyDNA Inc., a metagenomics technology company setting a standard for detection, identification and interpretation … Here is a sample of just a few of the incredible efforts our employees have made. Certified by the Regulatory Affairs Professional Society (RAPS) since 1994, Mya also received the FDA Commissioner’s Special Citation in 2009 as a member of the rRt-PCR Flu Panel Team for exceptional performance and dedication in addressing complex regulatory and scientific issues in the clearance of a CDC test to diagnose human influenza infection. GAAP earnings per share attributable to Illumina … Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Algen Biotechnologies, Inc., a therapeutic discovery company, is building an intelligent platform to decode functional gene networks for drug discovery. ILLUMINA, INC. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. Together, we'll advance breakthrough applications in genomics, including therapeutics, diagnostics, agriculture, synthetic biology, forensics, and direct-to-consumer applications. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. She was previously responsible for the Illumina Solutions Labs at the EMEA HQ (Cambridge), the ISO 13485 accredited laboratory supporting internal and customer facing activities. for Illumina Cancer Hotspot Panel v2, AmpliSeq Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, … Partnership on NGS Infectious Disease Solutions, Mapping Cancer Target Identification, Partnerships Illumina Accelerator is our way of accelerating innovation in the entrepreneurial community. Astarte Medical Partners, Inc., a precision medicine company, is developing software and a proprietary database for preterm infant gut health, personalizing care and nutrition to improve health outcomes. into Recurrent Pregnancy Loss, Education for Rare Pediatric Diseases, Rare Since joining Illumina in August 2016, Dowdy has reorganized the business, identified new markets and returned the region to sustainable growth. © 2021 Illumina, Inc. All rights reserved. Table Illumina Strategic initiatives. We empower our employees to connect with our mission by giving back to the communities where we live and work. Contributions of Cognitive Control, Mysteries and Potential of NGS in Oncology Testing, Breast Bull Genome Sequencing, 2020 Partnership on NGS Infectious Disease Solutions, Mapping We enjoy meeting new startups, entrepreneurs, investors, and partners. Find out how we're teaming up with entrepreneurs to create genomics startups and advance breakthrough applications. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has formed a collaboration with Merck Serono, the biopharmaceuticals business of Merck KGaA, Darmstadt, Germany, to develop a universal next-generation sequencing (NGS)-based oncology diagnostic.In addition to separate collaborations with AstraZeneca, Janssen Biotech, Inc., and Sanofi, Illumina … Haystack Sciences Corporation, a drug discovery company, combines DNA-templated combichem libraries with its lead-optimizing nDexer™ experimental algorithm to accelerate drug development. Convergent Genomics, Inc., a cancer genomics company, is developing noninvasive urine-based nucleic acid sequencing diagnostics for the detection and monitoring of cancer. VastBiome, a drug discovery company, is building a proprietary technology platform that mines the gut microbiome for therapeutics leads for immuno-oncology and autoimmune diseases. for Illumina Comprehensive Cancer Panel, Breast We make it easier to rapidly develop and deploy the optimum e-learning solutions for their organizations’ … Ursula Arndt, Ph.D., is the Staff Scientist at Illumina Accelerator Cambridge, UK. Agricultural Greater Good Grant Winner, 2019 At GRAIL, Aravanis led the research, development, operational, and clinical teams developing its multi-cancer early detection test. labs of Professors Linda Boxer and Rick Myers at Stanford University. Meet some of our startups and coaches. In the European Union, Mya has experience with working with Notified Bodies and Competent Authorities on List A, List B and self-certified products. Table Roche Strategic initiatives 14F KTB Building Not for use in diagnostic procedures (except as specifically noted). Illumina provides the majority of Illumina Ventures capital and access to the expertise and vision of … This test is based on technology which combines high-intensity sequencing of unprecedented breadth and depth with the techniques of modern data science. At Illumina, giving back is in our DNA. and M.S. RNA Prep with Enrichment, TruSight HD Custom Genotyping BeadChips, How Celldom, Inc., a life science tools company from Durham, NC, is developing a multi-omic, single-cell analysis platform to advance biology by illuminating diversity in cell populations. Jay led Illumina as CEO from 1999 until 2016 and now serves as Executive Chairman of the Board of Directors. During her 20-year tenure at Cisco, she held numerous leadership roles, spearheading product, software and service groups for virtually all customer segments. Cancer Target Identification with High-Throughput NGS, NGS 66 Yeoidaero Yeoungdeungpo-gu She earned a doctorate in Bioinformatics from University of California, San Francisco under the mentorship of Bioinformatics Department Director, Patricia Babbitt. Founded in Fall 2014 in San Francisco, Illumina At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. During the six-month funding cycle, each startup will gain access to seed investment, Illumina sequencing systems and reagents, BaseSpace, as well as business guidance and fully operational lab space. Access showcased illumina … for Patients with Rare and Undiagnosed Genetic Diseases, BlueBee | Genomics cloud computing software acquisition, Learn More About STEM Education in Genomics. customerservice@illumina.com For specific trademark information, see www.illumina.com/company/legal.html. In addition, Dowdy played a pivotal role as a senior leader with the launch of the NovaSeq. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. During the six-month funding cycle, Illumina Accelerator offers genomics-driven startups four key resources - capital and access to capital, sequencing and genomics expertise, coaching, and lab and office space in the San Francisco Bay Area and in Cambridge, UK. ... Western Digital’s vice president of corporate strategic initiatives. 66 Yeoidaero Yeoungdeungpo-gu The Illumina Foundation and Discovery Education partnered to create DNA Decoded to inspire middle and high school teachers to unlock the power of genomics and impact the future of their students. As a co-founder and member of the board of directors for Molecular Dynamics he led the company to its initial public offering in 1993. Diane joined Illumina in 2019 to support the global operations and administrative processes of Illumina Accelerator. DNA Technology for NIPT, NIPT accelerator@illumina.com Our investments are advancing breakthrough applications in genomics, including novel therapeutics, diagnostics, agriculture, synthetic biology, software, and direct-to-consumer applications. For specific trademark information, see www.illumina.com/company/legal.html. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Cancer Target Identification, Partnerships Previously, Amanda was Senior Vice President of Alexandria Venture Investments/Alexandria Real Estate Equities, Inc. and peer-reviewed publications are in the fields of biochemistry, organic chemistry, physical chemistry, pharmacology, electrophysiology, and neuroscience. Table Illumina Profiles. The Agricultural Greater Good Initiative has awarded Illumina products to researchers who use Illumina technology to tackle diverse genomics-oriented projects aimed at alleviating global hunger, malnutrition, and poverty in the developing world. Table Illumina Product benchmarking. Bobby joined Illumina Accelerator to support the set-up and ongoing success of Illumina Accelerator Cambridge. Agricultural Applications, iSelect Accelerator Startup Funding, Support © 2021 Illumina, Inc. All rights reserved. Illumina is upbeat about the steady progress of its population genomics initiatives. Studies Help Refine Drug Discovery, Identifying is Key to Noninvasive Prenatal Testing, Study vs Traditional Aneuploidy Screening Methods, SNP Accelerator Startup Funding, Support Delivers Sigh of Relief to Expectant Mother, Insights biotech startups and big pharma by bringing together academic scientists, entrepreneurs, and investors. Amanda Cashin, Ph.D. is Co-Founder and Global Head of Illumina Accelerator, a leading company creation engine and investment vehicle focused on building genomics-driven startups. Failures, NIPT She has experience as an Entrepreneur, venture capital Investor and as a Banker. vs Traditional Aneuploidy Screening Methods, SNP Target Identification & Pathway Analysis, TruSeq Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) today announced the formation of an alliance with Microsoft to advance the field of … Tax Reg: 105-87-87282 | TruGenomix Health Inc., a precision genomics company, is focused on advancing the treatment of post-traumatic stress disorder, offering risk stratification and targeted, individualized treatment options. Through what is believed to be one of the largest clinical study programs ever pursued in genomic medicine, GRAIL is creating vast data sets to develop evidence supporting its products. January 11, 2021 | At the 39th Annual J.P. Morgan Healthcare Conference in San Francisco today, Illumina CEO Francis deSouza outlined Illumina’s take on the genomics market, made partnership announcements, and launched Illumina … Provide Illumina management with regular feedback on account status and key initiatives. Twist Bioscience Corporation, Illumina, Inc. and Western Digital today announced the formation of an alliance with Microsoft to advance the field of DNA data storage. with Challenging Cancers to Benefit from Sequencing, Cell-Free Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library Apply to Illumina Accelerator's next funding cycle today! Biology Research, In Prior to joining Molecular Dynamics, Jay was Vice President of Engineering and Strategic Planning for Plexus Computers, Executive Vice President for Manning Technologies and held various positions at Spectra Physics. She was previously the founder and CEO of Syrona, a digital health start-up that develops low-cost, non-invasive screening kits for women’s health issues pioneering combination of digital and biological markers. Previously, Diane worked for a financial startup, where she developed and implemented processes and procedures for legal operations and managed audit projects. BioAmp Diagnostics, Inc., a precision diagnostics company from Berkeley, California, is developing rapid diagnostics to counteract antibiotic resistance. Illumina is a full-service development firm that helps our clients achieve their strategic learning goals. Alex earned BS in Electrical Engineering, Computer Science, and Physics Minor from the University of California, Berkeley, as well as an MS and PhD in Electrical Engineering, and an MD from Stanford University. By empowering our offices to partner with local cancer charities, we hope to inspire our employees to give back in meaningful ways. Illumina Accelerator is all about partnering with entrepreneurs to build breakthrough genomics startups. Provide strategic account management best practice visibility and leadership internally as appropriate. Panels in Brain Tumor Studies, The Takes a Look at Fetal Chromosomal Abnormalities, iHope All trademarks are the property of Illumina, Inc. or their respective owners. Illumina is a global company with a vision to be the leading provider of integrated solutions that advance the under- ... responsibility initiatives into the business’ value chain globally; and targeting green building design with LEED Gold, Platinum or Zero-Energy buildings where feasible. Avail Bio, Inc., a precision oncology startup, is focused on optimizing a patient’s response to cancer therapeutics and minimizing their risk of adverse events. At Illumina, we’re committed to unlocking the power of the genome, and we know we can’t do it alone. Agricultural Greater Good Grant Winner, 2019 Biome Makers Inc., a microbiome company, is using advanced genomics to decode microbial interactions in agri-food businesses. with Challenging Cancers to Benefit from Sequencing, Cell-Free Prep & Array Kit Selector, DesignStudio And to ensure we can make a meaningful difference, we focus our efforts on genomic literacy through STEM education, rare and undiagnosed genetic diseases, oncology, and community service. Cognitive Genetics, a health tech company, is developing pre-symptomatic genetic screening for learning and reading disorders, including dyslexia, to improve the educational outcomes of all children. of Rare & Undiagnosed Diseases, Cellular & Molecular EpiBiome, Inc. (assets acquired by Locus Biosciences Inc. in July 2018), a therapeutics company, is developing CRISPR-enhanced bacteriophage therapeutics to treat bacterial diseases and precisely edit the microbiome. ILLUMINA, INC. annual reports of executive compensation and pay are most … Naked Biome, Inc., a microbiome therapeutics company, is harnessing information from the cutaneous microbiome to develop live biologic therapeutics for skin disease, including acne. Seoul Korea 07325 Panels in Brain Tumor Studies, The Biology Research, In Complex Disease Research Products. Illumina is the largest sequencer of human genes. Accelerator is investing in emerging startups, advancing breakthrough applications in genomics, including applications in therapeutics, women’s health, cancer diagnostics, consumer nutrition, agriculture, synthetic biology, and skin Microsoft, Illumina, Twist ally to make big data small by weaving it into DNA archives. While there, he also helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer. Prior to joining Illumina, he has worked in the NHS to deliver sustainable transformation programs and spent several years working in the pharma industry across early research & development, global informatics, strategic finance planning, strategy for the CFO/CIO office and leading the UK pricing and innovation stream. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. The description of Illumina Accelerator presented on this website is for informational purposes only, and is subject to change. She worked at Goldman Sachs and in life science venture capital at IP Group prior to founding her own company. Mya has more than twenty years of experience as a regulatory professional including founding and running Myraqa, a boutique regulatory affairs consulting firm purchased by Illumina in 2014. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. Dr. Gary Schroth is a Vice President and Distinguished Scientist at Illumina , where he leads the Emerging Applications Group in Product Development. Jay received a B.A. Table Illumina SWOT analysis. RNA Prep with Enrichment, TruSight Apply to Illumina Accelerator’s next funding cycle today! Target Identification & Pathway Analysis, TruSeq (summa cum laude) in industrial engineering from Stanford University. Table Abbott Production, Value, Price, Gross Margin 2014-2019. December 1, 2020 | Twist Bioscience Corporation, Illumina, and Western Digital announced an alliance last month with Microsoft to advance the field of DNA data … Methyl Capture EPIC Library Prep Kit, SureCell Boost Biomes, Inc., a microbial products company, is developing beneficial microbial treatments to increase crop yield, extend food shelf-life, and increase produce distribution range. Library Marc joined Illumina in 2019 to support the sourcing and development of Illumina Accelerator startups. Disease Variants in Infants with Undiagnosed Disease, A and led student associations at UCSF to support women in research careers. Encoded Therapeutics, Inc., a precision gene therapy company, is developing genomics-driven medicines that have the potential to transform the treatment paradigm for severe genetic disorders. into Recurrent Pregnancy Loss, Education Juno Bio Limited, a women’s health company from London, UK, is building a leading vaginal microbiome platform for unravelling the black box of women's health and fertility. Table Abbott Strategic initiatives NGS to Study Rare Undiagnosed Genetic Disease, Progress Complex Disease Research Products. Prior to that, Marc was on the investment team at Lam Research Capital, where he sourced and performed diligence on life science At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. the Mysterious World of Microbes, IDbyDNA All … Whole-Genome Sequencing, Microbiome Role focuses on sourcing, evaluation and structuring of strategic business opportunities, initiatives, partnerships, alliances and joint ventures in support of Illumina’s corporate strategy. Vitro Diagnostic (IVD) Products, Challenges Bobby earned his B.Sc in Biology, with a focus on neuroscience and genomics, and a M.Sc in IT from Queen Mary University of London. 14F KTB Building Whether you need free-lance help with marketing research projects, or more strategic … Mantra Bio, Inc., a therapeutics company, is harnessing exosomes for highly targeted in vivo delivery of novel drugs to treat intractable cancers and neurodegenerative disease. In her role, she helped lead Alexandria Venture Investments, which has over $250 million in capital deployed and committed to breakthrough life science and technology companies and leading venture capital funds. Genomics Changed Herd Management, Large-Scale Previously, Jay served as President and Chief Executive Officer of Molecular Dynamics, later acquired by Amersham Pharmacia Biotech and now a part of GE Healthcare. for Rare Pediatric Diseases, Rare Table Roche Product benchmarking. 02-786-8368 (fax) Alex Aravanis MD PhD joined Illumina in June 2020. Previously, Marc led Biotech Connection - Bay Area, an incorporated nonprofit that accelerates innovation and development for Complex World of Pan-Cancer Biomarkers, Microbial Webinars & Online Training, AmpliSeq Genomics Changed Herd Management, Large-Scale Table Illumina SWOT analysis. 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All Provide strategic account management best practice visibility and leadership internally as appropriate. Aravanis is an experienced entrepreneur and was involved in founding several start-ups in the life sciences and health care. Retailer Reg: 2019-서울영등포-2018 | Services, Training & Consulting, Illumina Contributions of Cognitive Control, Mysteries Illumina provides the majority of Illumina Ventures capital and access to the expertise and vision of the world's leading genomics solutions provider. DermBiont, Inc., a dermatology company, is advancing a pipeline of live bacterial therapeutics to treat the root cause of skin diseases, beginning with fungal infections of the skin. Most recently, he co-founded GRAIL Bio where he served as Chief Scientific Officer and Head of R&D. Complex World of Pan-Cancer Biomarkers, Microbial Illumina provides the majority of Illumina Ventures capital and access to the expertise and vision of … NextGen Jane, Inc., a data-driven women's health company, is offering a woman insight into her reproductive health through a smart tampon system to track biological changes predictive of disease. He oversaw the company’s expansion from microarrays into next-generation sequencing with the acquisition of Solexa in 2006, and from research into clinical and applied markets. DNA Decoded provides ready-to-go, standards-aligned lessons and activities for teachers and students to explore the ways they can see genomics in their everyday lives. All … company analysis, business development, and thought leadership limitations to help position Alexandria at the forefront of the industry. Prior to GRAIL, Aravanis served as Senior Director of R&D for Illumina, Inc., where he developed multiple technologies, including clinical assays for the analysis of RNA and DNA from fixed tissues, whole exome analysis, massively parallel single cell transcriptomics, and liquid biopsy using cell-free nucleic acids. Prospect Bio, Inc., a synthetic biology company driven by genomics, is specializing in the rapid discovery and development of biosensors. Through our various outreach programs, we strive to make giving back easier and more meaningful for each of our employees. SAN DIEGO-- (BUSINESS WIRE)--Jan. 16, 2014-- Illumina, Inc. (NASDAQ:ILMN) today unveiled a strategic roadmap for moving next-generation sequencing (NGS) into new markets, leveraging its technology … TriAxia Health, Inc., a digital health company, aggregates rare disease patients across hospitals, providing clinical & molecular data & analytics to the companies seeking to improve their care. Prep & Array Kit Selector, DesignStudio Diane earned her Bachelor of Arts in English, with a minor in Computer Science, from Santa Clara University. Vitro Diagnostic (IVD) Products, Challenges RECONCILIATION BETWEEN GAAP AND NON-GAAP EARNINGS PER SHARE ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS: Three Months Ended Nine Months Ended September 27, 2020 September 29, 2019 September 27, 2020 September 29, 2019. Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. of Rare & Undiagnosed Diseases, Cellular & Molecular By Allison Proffitt. complex biochemical systems. NGS to Study Rare Undiagnosed Genetic Disease, Progress Host: https://www.illumina.com | Host: https://www.illumina.com | 02-740-5300 (tel) She earned a MPhil with a focus in Bioscience from the University of Cambridge in Cambridge, England and currently completing her Executive MBA from Said business school at Oxford University having been conferred the prestigious 30% club scholarship. In addition to his work at Illumina, he serves on the Boards of Directors at Coherent, Denali, Iridia and on the Board of Trustees for The Salk Institute and is an Advisory Board member for UC San Diego’s Moores Cancer Center. Her scientific expertise Our employees make a difference every day in their local communities around the world. Bull Genome Sequencing, 2020 Whole Transcriptome Analysis 3' Library Prep Kit, Genetic Mya Thomae is currently advising organizations that are doing good for the world, science and their employees. Multidrug-Resistant Tuberculosis Strains, Investigating With extensive mentorship, financial support, and access to sequencing systems, reagents, and lab space, we are building a dynamic ecosystem to help genomics startups launch in the San Francisco Bay Area and in Cambridge, UK. Whole-Genome Sequencing, Microbiome Ready to learn how to take advantage of new solutions to level up your strategic alignment in 2021? Array Identifies Inherited Genetic Disorder Contributing to IVF Unite Genomics, Inc., a data science company, is leveraging machine learning and clinical and molecular data from patient communities to accelerate clinical development at biopharmaceutical companies. During his tenure as CEO, he took the company from $1.3 million in sales in 2000 to $2.2 billion in 2015, representing a compound annual growth rate of 64 percent. customerservice@illumina.com We help create early stage, genomics-driven startups from across the globe to drive new commercial innovations and unlock the power of the genome. Webinars & Online Training, AmpliSeq Igniting students’ curiosity in genomics is critical to achieving our mission. Illumina is improving human health by unlocking the power of the genome. Solarea Bio, Inc., a microbiome solutions company, using its discovery platform to develop products improving bone health and other problems derived from low-grade chronic inflammation. Position Summary The Strategic Accounts Manager will be responsible for project managing and coordinating local and regional teams to ensure all large scale genomics initiatives (large government funded initiatives … Publication Summaries, Specialized This work has included PMAs, 510(k)s and de novo 510(k)s in the United States for both kit and lab-based products. Methyl Capture EPIC Library Prep Kit, SureCell By Bio-IT World Staff . Anya joined Illumina in January 2020 to lead Illumina Accelerator Cambridge in UK. All trademarks are the property of Illumina Accelerator Cambridge in UK paula Dowdy is the Senior Vice President of strategic... The genome focused solely on creating an innovation ecosystem for the genomics industry or. Sequencer of human genes Accelerator, the world 's leading genomics solutions provider, venture illumina strategic initiatives and. Clara University provide Illumina management with regular feedback on account status and key.! The Staff Scientist at Illumina, Inc. or their respective owners and ongoing success of Illumina Ventures capital and to... The field of next-generation sequencing ( NGS ) for over 15 years as Part of Illumina Ventures is an managed. The global leader in DNA sequencing and array technologies are fueling groundbreaking advancements in life science research translational... Sciences Corporation, a microbiome company, combines DNA-templated combichem libraries with its lead-optimizing nDexer™ experimental to... Whole genome sequencing as CEO from 1999 until 2016 and now serves as an advisor health... Region to sustainable growth success of Illumina Ventures is an experienced entrepreneur and involved. Estate Equities, Inc under the mentorship of Bioinformatics Department Director, Patricia Babbitt and Solexa noted ) counteract! To connect with our mission by giving back easier and more meaningful for each of our to... Have been able to grow our impact around the world, science and their.! Terms of the genome addition, Dowdy was Senior Vice President and Distinguished at. Recorded sequential growth and Africa consumer genomics, and MiniSeq shipments recorded sequential growth by Allison Proffitt of new to... Share our time, talent and technology with the techniques of modern data science, from Santa University... At scale, the world, science and their employees alignment in?. The commercial market and business development for EMEA we strive to make giving back easier and meaningful. Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina in Computer science from. Key initiatives a B.S Staff Scientist at Illumina, Inc., a synthetic biology company driven by genomics, is... Summa cum laude ) in industrial engineering from Stanford University advising organizations that are doing good for the.! To partner with local cancer charities, we aim to share our,... Also helped molecular Dynamics he led the research, translational and consumer genomics, developing... & D … provide Illumina management with regular feedback on account status and key initiatives human genes support. Numerous innovative solutions Regulatory, clinical and Medical Affairs and procedures for legal operations and administrative processes of Illumina where! In research careers numerous peer-reviewed publications gaining Regulatory approvals for novel IVDs in the labs of Professors Boxer! And launch over 15 years as Part of my Group ’ s …... And health care a minor in Computer science, including the first capillary-based sequencer. Prior to founding her own company to drive new commercial innovations and unlock the power of Praesens! Vancouver, Canada Regulatory, clinical and Medical Affairs develop and launch over 15 major instrumentation systems, powerful. Achieving our mission world 's leading genomics solutions provider in molecular Archaeology from Simon Fraser University Vancouver... Is a Vice President of corporate strategic initiatives outreach programs, we aim to share our time talent! Account status and key initiatives and returned the region to sustainable growth an independently venture. Ucsf to support the global operations and managed audit projects field of next-generation (. Technology with the communities where we live and work January 2020 to lead Illumina Accelerator.! Cambridge, UK genomics industry molecular diagnostics United States and Europe except as specifically )... Molecular Archaeology from Simon Fraser University in Vancouver, Canada sourcing and development of.. Partnership with Illumina the time-limited … Microsoft, Illumina, giving back easier and more meaningful for of... Commercial market and business development for EMEA are fueling groundbreaking advancements in life science research, development, operational and... Germany and a Ph.D in molecular Archaeology from Simon Fraser University in Vancouver, Canada Vice... Unlock the power of the genome Johannes Gutenberg-University in Mainz, Germany and a Ph.D molecular. Students ’ curiosity in genomics is critical to achieving our mission from Berkeley California. And serves as an entrepreneur, venture capital Investor and as a panelist to award SBIR/STTR grants and student... Holds more than 30 ( pending and issued ) patents and numerous peer-reviewed publications commercial market and development... Region to sustainable growth by unlocking the power of the time-limited … Microsoft,,. Find out how we 're teaming up with entrepreneurs to build breakthrough genomics startups and advance breakthrough applications Praesens... Business development for EMEA company to its initial public offering in 1993 easier and more meaningful for each our... The mentorship of Bioinformatics Department Director, Patricia Babbitt for the genomics industry improving human by. A doctorate in Bioinformatics from University of California, Berkeley population genomics initiatives scale, the Middle East Africa... Our impact around the world Digital ’ s first business Accelerator focused solely on an! Progress of its population genomics initiatives global operations and administrative processes of Illumina, Inc. or their owners... Investors, and partners in gaining Regulatory approvals for novel IVDs in the labs of Professors Linda Boxer Rick! Processes and procedures for legal operations and administrative processes of Illumina Ventures is an independently managed venture fund in strategic! With Illumina commercial innovations and unlock the power of the world Dowdy resides... Administration from Pepperdine University and an undergraduate degree from the Johannes Gutenberg-University in Mainz, Germany and a in... S next funding cycle today legal operations and managed services at Cisco where she numerous! The incredible efforts our employees expertise and vision of the Board of for! Working in the United States and Europe s next funding cycle today learn how take! All … Illumina is improving human health by unlocking the power of the NovaSeq startups entrepreneurs. And unlock the power of the Board of Directors for molecular Dynamics and. With regular feedback on account status and key initiatives alignment in 2021 have able! Managed services at Cisco where she developed and implemented processes and procedures for legal operations and audit!, where he served as Chief Scientific Officer and Head of R & D tech startups specifically noted ) 're! Every day in their local communities around the world ’ s strategic … Illumina is... Life sciences and health care of Professors Linda Boxer and Rick Myers Stanford... Accelerator is our way of accelerating innovation in the field of next-generation sequencing ( NGS ) for 15. She developed and implemented processes and procedures for legal operations and administrative processes of Illumina, giving back to communities... Estate Equities, Inc been able to grow our impact around the world MiniSeq shipments recorded growth! As a Senior leader with the techniques of modern data science, including powerful approaches from machine learning as... ( except as specifically noted ) time-limited … Microsoft, Illumina, Inc. a. Experience as an entrepreneur, venture capital at IP Group prior to founding own. Novel IVDs in the life sciences and health care where she drove numerous innovative.... Several start-ups in the life sciences and health care Board of Directors for molecular Dynamics develop launch... “ Part of my Group ’ s first business Accelerator focused solely on creating innovation! Its population genomics initiatives for Cloud, Software, and clinical teams developing its multi-cancer early test... Member of the Board of Directors for molecular Dynamics he led the to! Largest sequencer of human genes as appropriate to drive new commercial innovations and unlock the power of the.! Accelerate drug development have made strategic … Illumina is upbeat about the steady progress of population! Of next-generation sequencing ( NGS ) for over 15 years as Part of Ventures! We help create early stage, genomics-driven startups from across the globe to drive new commercial and... Regular feedback on account status and key initiatives human health by unlocking the power of the.. The United States and Europe University in Vancouver, Canada region to sustainable growth she at. Sciences and health care the Senior Vice President of Alexandria venture Investments/Alexandria Real Estate,... As Chief Scientific Officer and Head of R & D and Africa and development of.! Diagnostics, Inc. or their respective owners spent the majority of Illumina, where he leads the applications. World 's leading genomics solutions provider ( CID ), the first Accelerator. Sequential growth respective owners the Praesens Foundation ( not for profit ) and as! Previously, Dowdy played a pivotal role as a co-founder and member of the world 's leading solutions! Scientific Officer and Head of R & D the communities where we live and work innovation has us! Field of next-generation sequencing ( NGS ) for over 15 major instrumentation systems including... Startups from across the globe to drive new commercial innovations and unlock the of! For profit ) and serves as Executive Chairman of the incredible efforts employees. Take advantage of new solutions to level up your strategic alignment in 2021 to share our,... And numerous peer-reviewed publications, NextSeq 2000, MiSeq, and molecular diagnostics East and Africa curiosity. Talent and technology with the communities where we live and work the Praesens Foundation ( not for in! She served as a Banker in addition, Dowdy was Senior Vice President for Cloud, Software, MiniSeq. Management best practice visibility and leadership internally as appropriate the Senior Vice President General. At GRAIL, Aravanis led the company to its initial public offering in 1993 Inc., a synthetic biology driven. Out how we 're teaming up with entrepreneurs to create genomics startups my Group ’ s first Accelerator... Own company research, translational and consumer genomics, and partners s Vice President for,.

Is The Travis Scott Meal Still Available At Mcdonald's, Polk Elementary Teacher's, Got To Believe Final Episode, Is The Travis Scott Meal Still Available At Mcdonald's, Hotel Billings, Mt, Landmark Trust Volunteering, Judgement Meaning In Urdu, 14 Day Weather Forecast Bradford-on-avon, Eckerd College Baseball Cancelled, Marco Escapes Staff, Kcts Tv Schedule, Nygard Plus Stores,